Drugs Information:
Nadolol
Basic Information
|
||
ID | DDInter1255 | |
Drug Type | small molecule | |
Molecular Formula | C17H27NO4 | |
Molecular Weight | 309.401 | |
CAS Number | 42200-33-9 | |
Description | Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects.[A34177] Nadolol was granted FDA approval on 10 December 1979.[L7922] | |
ATC Classification | C07BA12 C07AA12 | |
IUPAC Name | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol | |
InChI | VWPOSFSPZNDTMJ-UCWKZMIHSA-N | |
Canonical SMILES | CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2 | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Guide to Pharmacology Wikipedia ChEMBL |
Interactions with
Nadolol
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|